C.M. Bidwell & Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113 | Hold |
12
| – | – | ﹤0.01% | 444 |
|
|
2025
Q1 | $85 | Hold |
12
| – | – | ﹤0.01% | 438 |
|
|
2024
Q4 | $140 | Hold |
12
| – | – | ﹤0.01% | 481 |
|
|
2024
Q3 | $247 | Sell |
12
-1,697
| -99% | -$34.9K | ﹤0.01% | 495 |
|
|
2024
Q2 | $38.2K | Buy |
1,709
+282
| +20% | +$6.31K | 0.03% | 242 |
|
|
2024
Q1 | $39.3K | Buy |
1,427
+1,415
| +11,792% | +$38.9K | 0.03% | 238 |
|
|
2023
Q4 | $366 | Sell |
12
-39
| -76% | -$1.19K | ﹤0.01% | 463 |
|
|
2023
Q3 | $1.61K | Hold |
51
| – | – | ﹤0.01% | 489 |
|
|
2023
Q2 | $2.08K | Hold |
51
| – | – | ﹤0.01% | 471 |
|
|
2023
Q1 | $1.9K | Hold |
51
| – | – | ﹤0.01% | 476 |
|
|
2022
Q4 | $1.78K | Buy |
51
+39
| +325% | +$1.36K | ﹤0.01% | 462 |
|
|
2022
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 457 |
|
|
2022
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 464 |
|
|
2022
Q1 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 501 |
|